Limitations, agreements, and source contact

APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma · Source last updated 2020-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

GT60

restrictive Agreement

true

limitations And Caveats

description

Early termination leading to small numbers of patients analyzed

point Of Contact

email

clinicaltrials@autolus.com

organization

Autolus Ltd

phone

+44 1483 920748

title

Clinical Project Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice